相似文献
1
TGF-beta signaling and the role of inhibitory Smads in non-small cell lung cancer.
J Thorac Oncol. 2010 Apr;5(4):417-9. doi: 10.1097/JTO.0b013e3181ce3afd.
2
Repression of TIF1γ by SOX2 promotes TGF-β-induced epithelial-mesenchymal transition in non-small-cell lung cancer.
Oncogene. 2016 Feb 18;35(7):867-77. doi: 10.1038/onc.2015.141. Epub 2015 May 11.
3
Role of TGF-β signaling in curcumin-mediated inhibition of tumorigenicity of human lung cancer cells.
J Cancer Res Clin Oncol. 2013 Apr;139(4):563-72. doi: 10.1007/s00432-012-1352-6. Epub 2012 Nov 16.
4
RNF111/Arkadia is regulated by DNA methylation and affects TGF-β/Smad signaling associated invasion in NSCLC cells.
Lung Cancer. 2015 Oct;90(1):32-40. doi: 10.1016/j.lungcan.2015.07.010. Epub 2015 Jul 26.
5
Effects of TGF-β signaling blockade on human A549 lung adenocarcinoma cell lines.
Mol Med Rep. 2011 Sep-Oct;4(5):1007-15. doi: 10.3892/mmr.2011.530. Epub 2011 Jul 1.
6
Transforming growth factor-beta 1 and its receptors in human lung cancer and mouse lung carcinogenesis.
Exp Lung Res. 2000 Dec;26(8):685-707. doi: 10.1080/01902140150216765.
7
CCT6A suppresses SMAD2 and promotes prometastatic TGF-β signaling.
J Clin Invest. 2017 May 1;127(5):1725-1740. doi: 10.1172/JCI90439. Epub 2017 Apr 4.
8
Chinese medicine Bu-Fei decoction attenuates epithelial-mesenchymal transition of non-small cell lung cancer via inhibition of transforming growth factor β1 signaling pathway in vitro and in vivo.
J Ethnopharmacol. 2017 May 23;204:45-57. doi: 10.1016/j.jep.2017.04.008. Epub 2017 Apr 12.
9
Smad7 Protein Interacts with Receptor-regulated Smads (R-Smads) to Inhibit Transforming Growth Factor-β (TGF-β)/Smad Signaling.
J Biol Chem. 2016 Jan 1;291(1):382-92. doi: 10.1074/jbc.M115.694281. Epub 2015 Nov 10.
10
Ski prevents TGF-β-induced EMT and cell invasion by repressing SMAD-dependent signaling in non-small cell lung cancer.
Oncol Rep. 2015 Jul;34(1):87-94. doi: 10.3892/or.2015.3961. Epub 2015 May 7.
引用本文的文献
1
Recent advances in therapeutic use of transforming growth factor-beta inhibitors in cancer and fibrosis.
Front Oncol. 2025 Apr 25;15:1489701. doi: 10.3389/fonc.2025.1489701. eCollection 2025.
2
Comprehensive multimodal and multiomic profiling reveals epigenetic and transcriptional reprogramming in lung tumors.
Commun Biol. 2025 Mar 31;8(1):527. doi: 10.1038/s42003-025-07954-8.
3
Exploring the Role of the TGF-β Signaling Pathway in Colorectal Precancerous Polyps Biochemical Genetics.
Biochem Genet. 2025 Apr;63(2):1116-1148. doi: 10.1007/s10528-024-10988-y. Epub 2024 Dec 5.
4
Overcoming EGFR-TKI resistance by targeting the tumor microenvironment.
Chin Med J Pulm Crit Care Med. 2024 Sep 16;2(3):151-161. doi: 10.1016/j.pccm.2024.08.002. eCollection 2024 Sep.
5
Therapeutic targeting of TGF-β in lung cancer.
FEBS J. 2025 Apr;292(7):1520-1557. doi: 10.1111/febs.17234. Epub 2024 Jul 31.
6
Cholesterol and Immune Microenvironment: Path Towards Tumorigenesis.
Curr Nutr Rep. 2024 Sep;13(3):557-565. doi: 10.1007/s13668-024-00542-y. Epub 2024 May 2.
7
Paracrine Regulation and Immune System Pathways in the Inflammatory Tumor Microenvironment of Lung Cancer: Insights into Oncogenesis and Immunotherapeutic Strategies.
Cancers (Basel). 2024 Mar 10;16(6):1113. doi: 10.3390/cancers16061113.
8
TGF-β as Predictive Marker and Pharmacological Target in Lung Cancer Approach.
Cancers (Basel). 2023 Apr 14;15(8):2295. doi: 10.3390/cancers15082295.
9
Super-enhancer hijacking LINC01977 promotes malignancy of early-stage lung adenocarcinoma addicted to the canonical TGF-β/SMAD3 pathway.
J Hematol Oncol. 2022 Aug 18;15(1):114. doi: 10.1186/s13045-022-01331-2.
10
Salvianolic acid B acts against non‑small cell lung cancer A549 cells via inactivation of the MAPK and Smad2/3 signaling pathways.
Mol Med Rep. 2022 May;25(5). doi: 10.3892/mmr.2022.12700. Epub 2022 Mar 29.
本文引用的文献
1
Single nucleotide polymorphism at rs1982073:T869C of the TGFbeta 1 gene is associated with the risk of radiation pneumonitis in patients with non-small-cell lung cancer treated with definitive radiotherapy.
J Clin Oncol. 2009 Jul 10;27(20):3370-8. doi: 10.1200/JCO.2008.20.6763. Epub 2009 Apr 20.
2
Elevation of plasma TGF-beta1 during radiation therapy predicts radiation-induced lung toxicity in patients with non-small-cell lung cancer: a combined analysis from Beijing and Michigan.
Int J Radiat Oncol Biol Phys. 2009 Aug 1;74(5):1385-90. doi: 10.1016/j.ijrobp.2008.10.065. Epub 2009 Feb 21.
3
SMAD6 contributes to patient survival in non-small cell lung cancer and its knockdown reestablishes TGF-beta homeostasis in lung cancer cells.
Cancer Res. 2008 Dec 1;68(23):9686-92. doi: 10.1158/0008-5472.CAN-08-1083.
4
Inhibition of TGF-beta2 with AP 12009 in recurrent malignant gliomas: from preclinical to phase I/II studies.
Oligonucleotides. 2007 Summer;17(2):201-12. doi: 10.1089/oli.2006.0053.
5
Stable overexpression of Smad7 in human melanoma cells impairs bone metastasis.
Cancer Res. 2007 Mar 1;67(5):2317-24. doi: 10.1158/0008-5472.CAN-06-3950.
6
Effect of Smad7 expression on metastasis of mouse mammary carcinoma JygMC(A) cells.
J Natl Cancer Inst. 2005 Dec 7;97(23):1734-46. doi: 10.1093/jnci/dji399.
7
Non-Smad TGF-beta signals.
J Cell Sci. 2005 Aug 15;118(Pt 16):3573-84. doi: 10.1242/jcs.02554.
8
Selective inhibitors of type I receptor kinase block cellular transforming growth factor-beta signaling.
Biochem Pharmacol. 2004 Jul 1;68(1):41-50. doi: 10.1016/j.bcp.2004.03.011.
9
SB-505124 is a selective inhibitor of transforming growth factor-beta type I receptors ALK4, ALK5, and ALK7.
Mol Pharmacol. 2004 Mar;65(3):744-52. doi: 10.1124/mol.65.3.744.
10
Smad7 but not Smad6 cooperates with oncogenic ras to cause malignant conversion in a mouse model for squamous cell carcinoma.
Cancer Res. 2003 Nov 15;63(22):7760-8.
Zotero 插件